Navigation Links
OLA4000 Clinical Lab Automation System

ProductsOLA4000 Clinical Lab Automation System
Company Olympus America Diagnostics
Item OLA4000 Clinical Lab Automation System
Features Fully automate your chemistry-immuno pre-analytical processes
  • System throughput of 400 tubes per hour for pre-analytical processes
  • Minimal operator interaction as all sample-processing and analysis is completed within the workcell
  • Primary tube processing no aliquotting required
  • User-defined applications for centrifugation, decapping, sample analysis, and output sorting.
  • Processes most primary sample tubes and closures
  • User defined output sorting allows building of any personality racks for others after analysis

Complete workcell integration

  • Fully automate pre-analytical sample-processes
  • Load balance two identical analyzers or uniquely configure analyzers for flexibility
  • Automatic analyzer feed of calibrators and controls from a refrigerated storage compartment
  • Workcell software allows complete sample repeat and reflex testing within the workcell

Flexible and easy to use Windows NT based software

  • Easy to use graphic user interface with real time update of system and instrument status
  • Specimen tracking enables quick identification of samples at the sorting areas
  • Central data processing unit for sample-processing and test results from connected analyzers

Different system configurations to fit your needs

  • "Configuration S" connects two Olympus AU640 analyzers yield an analytical throughput of 2,400 tests per hour
  • "Configuration M" connects one Olympus AU640 and one Olympus AU2700 analyzer for an analytical throughput of 3,333 tests per hour
  • "Configuration L" combines two Olympus AU2700 analyzers with the sample-processing unit for an analytical throughput of 4,266 tests per hour
Description Streamline workflow and reduce costs associated with sample-processing with the Olympus OLA4000 workcell lab automation system. Designed for the medium- to high-volume hospital, core and commercial labs, it fully automates labor-intensive specimen processing tasks within the chemistry-immuno work area including sample identification, centrifugation, decapping and output sorting of specimen tubes. It also integrates two Olympus AU analyzers for automated rack loading and unloading along with centralized data processing for added convenience and efficiency.

The Olympus OLA4000 integrates sample-processing and analysis into a single workcell for increased productivity and efficiency in medium- to high-volume laboratories. It automates labor-intensive pre-analytical tasks such as sample identification, centrifuging, decapping, and output sorting, with automated connection to two Olympus AU analyzers.

Info Olympus America DiagnosticsCall Olympus America Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-651-9837

Customer Service: 1-800-645-8160, 610-391-2479
Web site: http://www.olympusamerica.com

Related medicine products :

1. Clinical DataBase
2. Freedom EVO Clinical
3. OLA2500 Clinical Lab Automation System
4. Aeroset Clinical Chemistry System
5. Express Plus Clinical Chemistry Analyzer
6. i-STAT Portable Clinical Analyzer
7. HAI CL-1000xyzClinical Specular Microscope
8. UniCel DxC 600 Synchron Clinical System
9. Clinical Information System
10. The Clinical Reference Laboratories at National Jewish Medical and Research Center
11. Dermatology, Allergy and Clinical Immunology (DACI) Reference Laboratory
...Low Binding 20l Barrier Tips. Low binding technolo...d proteins bound to the tip. Most other filter tip... focus is on liquid not adhering to the pipet tip....ich reduces the binding of valuable molecules such...
...rrier tips eliminate false signals and contaminati... tested, Promega Barrier Tips offer performance an...s (PCR(a)), radioactive isotopes, tissue culture f...l specimens. , ,Promega Barrier Tips are made with...
...l Resistant Tips offer a safe alternative to using...igned for applications such as PCR(a), pipetting r...ion, ART Tips are excellent for tissue culture, ge.... ART Tips prevent aerosol contaminants and liquid...
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote
Medicine Products:
(Date:9/8/2008)...pists, occupational therapists and other rehabilit...ent increases through 2016. , ...nificant milestones through the help and dedicatio...e http://www.nraf-rehabnet.org/ [National Rehabi...he 2008 National Rehabilitation Awareness Celebrat...
(Date:9/7/2008)...a growing obesity epidemic in the United States, r...al Center have new study results that indicate tha... where that fat is located when assessing risk for... "We are facing an obesity epidemic, which obvious...ardiovascular disease, etc.," said Jingzhong Ding,...
(Date:9/5/2008)...-USNewswire/ -- Children and,families across Penns...ervices to protect their health and well-being thr...nced today by the Department of Public Welfare., ...lies, the department,began developing the nation,s...tiative, ICSP, in 2004. Through this initiative, c...
(Date:9/5/2008)...hows Public Reluctant to Evacuate, Without Their C... Confirm Survey Result...by the American Humane,Association found that 47 p... if it meant leaving without their family pet. Wit...ds the U.S. coast, residents and,officials should ...
Breaking Medicine News(10 mins):Health News:U.S. Demand for Rehabilitation Professionals Grows 2Health News:U.S. Demand for Rehabilitation Professionals Grows 3Health News:'Healthy' individuals may be at risk for heart disease 2Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4
...is threatening to cause a major upheaval to the Na...he spread, according to the Coordinating Minister/...n’s Economic Minister, equally concerned, has expr... a consequent fall back in the Nation’s Economic c...
...icine, one should reevaluate new medicines and tre...D., Dr. Berry, professor and chair of the Depart...he University of Texas M. D. Anderson Cancer Cente...rials are designed and conducted in the U.S. He th...
...a Pechman ruled in Seattle that the Virginia Mason...shots or give up their jobs.// This ruling came af...e hospital had asked the 600-strong nursing staff ... duty" measure. In August last year, a labor arbit...
...a massive stroke on Jan 4 underwent a surgery sinc...The PM is in a critical situation and is 77 years ...ital in Jerusalem where he has already had seven h... and stop bleeding in his brain. As a statement by...
Other Medicine News:Health News:New Generation Clinical Trials Could Save Time And Money, Improve Patient Care 2
(Date:9/4/2008)...swire/ -- Cytopia Limited (ASX:,CYT) today announc...b/II,study of CYT997, the company,s novel vascular...aggressive form of brain cancer known as glioblast...the first Phase II efficacy study in highly,vascul...e second in its,suite of Phase II studies designed...
(Date:9/4/2008)...nd Presented at ESC Congress-, PHILADELPHIA, Sept...al,study, the GISSI Heart Failure (GISSI-HF) study...ers reduced all cause mortality and hospital,admis...chronic heart,failure. These findings are publishe...d were presented at the European Cardiovascular So...
(Date:9/4/2008)...Newswire/ -- Axentis Pharma AG has,initiated a cli...erability,of a new therapeutic formulation for the... fibrosis patients. The new formulation allows an,...ctly to the site of,infection. The forthcoming tri...doses of the new drug. Initial results are expecte...
(Date:9/4/2008)... with Two Abstracts Accepted for Presentation,... BRIDGEWATER, N.J., Sept. 4 /- Aeger...cal company focused on the treatment of,cardiovasc...pointment of,Peter L. Garrambone, Jr. to the Compa...er includes more than 50 pharmaceutical,transactio...
Breaking Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2ClearWay Minnesota 28SM 29 Board Approves 242 8 Million for Research Grants 6564 1ClearWay Minnesota 28SM 29 Board Approves 242 8 Million for Research Grants 6564 2ClearWay Minnesota 28SM 29 Board Approves 242 8 Million for Research Grants 6564 3First study of Australias high cost of pain reveals 2434 billion price tag 6562 1First study of Australias high cost of pain reveals 2434 billion price tag 6562 2MIT 3A Micro livers could aid drug screening 1258 1MIT 3A Micro livers could aid drug screening 1258 2MIT 3A Micro livers could aid drug screening 1258 3Mini Strokes 3A Major Health Threats 6558 1Mini Strokes 3A Major Health Threats 6558 2Mini Strokes 3A Major Health Threats 6558 3
...0-Patient Lung Cancer Diversity Study, CHICAGO, Ju...how,lung cancer is the leading cause of cancer dea...ected to be diagnosed,and 16,700 deaths expected t...he leading cause of cancer death in Hispanic men a...panic women.(ii),Researchers at Eli Lilly and Comp...
...of pivotal trial confirms that more patients,are a...ne 4, 2007-A follow-up analysis tracking,the outco...oma,(NHL) who were treated with the innovative can...ago has revealed exciting results,(1). , This anal...hown,that over half (53%) of the patients treated ...
Other Medicine Technology:Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 2Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 3Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 4Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 5Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 6Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 7Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 8Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 9Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 10Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 11MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 2MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 3MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 4